Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$2,884,638
-13.15%
Shares
Shares Volume: 91,634 Shares
Average Share Price: $31.48
INSIDER
Cheng Andrew
President and CEO (Director)
reported on Oct 18 2024
traded on Oct 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 605,417 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,040,381.18 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 38 |
| P/S VALUE RATIO | 0.188 |
| AVERAGE SALE VALUE | $515,879.68 |
| COMPANY PREVIOUS TRADES |